Silgan (SLGN) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
19 Oct, 2026Deal rationale and strategic fit
North American metal containers and food-and-beverage flat-cap closures combine with Trivium’s European operations to create a global metal-packaging platform with complementary products and geographic reach.
Trivium adds aerosol and aluminum beverage bottle offerings and strengthens European presence; scale is expected to support supply security, innovation and lower customer costs.
Distinct metal-packaging and Dispensing Solutions platforms will have separate growth opportunities and capital-allocation priorities.
Financial terms and conditions
All-cash acquisition values Trivium at $3.4B enterprise value, or 7.1x LTM adjusted EBITDA and 4.8x including expected synergies; contributed metal businesses are valued at $3.8B, or 8.1x LTM adjusted EBITDA.
AIP-affiliated funds invest ~$1.0B for 40% ownership; 60% controlling ownership is retained. Funding includes $4.9B of new debt and $1.5B of equity rollover, among total sources of $7.4B.
$2.3B cash proceeds are payable at closing, subject to customary adjustments, and are intended for debt repayment; the metal partnership is expected to have $4.6B net debt and 4.0x net leverage.
The partnership will have an independent balance sheet and be fully consolidated for financial reporting; its board will have three retained-owner representatives and two AIP representatives.
Pro forma net sales are $9.8B and adjusted EBITDA is $1.7B; adjusted EPS and free cash flow are each expected to be accretive by at least 15%.
Synergies and expected cost savings
Expected synergies total $225M by year three, with targets of $75M in year one and $150M in year two; initiatives span operations, procurement and SG&A.
Synergy mix is 50% operations, 30% procurement and 20% SG&A, with each category expected to be realized evenly over three years.
One-time synergy costs are expected to total ~$225M, with ~$100M in the first two years and the balance in year three.
Latest events from Silgan
- Record adjusted EPS and higher guidance amid muted demand; portfolio deals advance.SLGN
Q3 2026 - Q2 2026 sales up 7% with strong fragrance and pet food growth, but margins declined.SLGN
Q2 2026 - Q1 2026 sales up 6.4%, adjusted EPS $0.78, and full-year guidance increased.SLGN
Q1 2026 - Proxy covers director elections, incentive plan amendment, auditor ratification, and say-on-pay.SLGN
Proxy filing - Record 2025 growth in key segments, with further earnings and cash flow gains expected in 2026.SLGN
Q4 2025 - Q3 2024 saw record dispensing growth and Weener acquisition, setting up strong 2025 prospects.SLGN
Q3 2024 - €838M acquisition expands dispensing leadership, targets €20M synergies and 10% EPS accretion.SLGN
M&A Announcement - Q2 net sales fell 3.2% to $1.38B, but gross margin and adjusted EPS both increased.SLGN
Q2 2024 - Record Q4 results and 2025 double-digit growth outlook driven by acquisitions and dispensing demand.SLGN
Q4 2024